Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 21.

Mackenzie, I R A; Munoz, D G; Kusaka, H; Yokota, O; Ishihara, K; Roeber, S; Kretzschmar, H A; Cairns, N J; Neumann, M (2011). Distinct pathological subtypes of FTLD-FUS. Acta Neuropathologica, 121(2):207-218.

Neumann, M; Bentmann, E; Dormann, D; Jawaid, A; DeJesus-Hernandez, M; Ansorge, O; Roeber, S; Kretzschmar, H A; Munoz, D G; Kusaka, H; Yokota, O; Ang, L C; Bilbao, J; Rademakers, R; Haass, C; Mackenzie, I R A (2011). FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain: A Journal of Neurology, 134(9):2595-2609.

Otto, M; Ludolph, A C; Landwehrmeyer, B; Förstl, H; Diehl-Schmid, J; Neumann, M; Kretzschmar, H A; Schroeter, M; Kornhuber, J; Danek, A (2011). Konsortium zur Erforschung der frontotemporalen Lobärdegeneration. Der Nervenarzt, 82(8):1002-1005.

Van Deerlin, V M; Sleiman, P M A; Martinez-Lage, M; Chen-Plotkin, A; Wang, L S; Graff-Radford, N R; Dickson, D W; Rademakers, R; Boeve, B F; Grossman, M; Arnold, S E; Mann, D M A; Pickering-Brown, S M; Seelaar, H; Heutink, P; van Swieten, J C; Murrell, J R; Ghetti, B; Spina, S; Grafman, J; Hodges, J; Spillantini, M G; Gilman, S; Lieberman, A P; Kaye, J A; Woltjer, R L; Bigio, E H; Mesulam, M; Al-Sarraj, S; Troakes, C; Rosenberg, R N; White, C L; Ferrer, I; Lladó, A; Neumann, M; Kretzschmar, H A; Hulette, C M; Welsh-Bohmer, K A; Miller, B L; Alzualde, A; Lopez de Munain, A; McKee, A C; Gearing, M; Levey, A I; Lah, J J; Hardy, J; Rohrer, J D; Lashley, T; Mackenzie, I R A; Feldman, H H; Hamilton, R L; Dekosky, S T; van der Zee, J; Kumar-Singh, S; Van Broeckhoven, C; Mayeux, R; Vonsattel, J P G; Troncoso, J C; Kril, J J; Kwok, J B J; Halliday, G M; Bird, T D; Ince, P G; Shaw, P J; Cairns, N J; Morris, J C; McLean, C A; DeCarli, C; Ellis, W G; Freeman, S H; Frosch, M P; Growdon, J H; Perl, D P; Sano, M; Bennett, D A; Schneider, J A; Beach, T G; Reiman, E M; Woodruff, B K; Cummings, J; Vinters, H V; Miller, C A; Chui, H C; Alafuzoff, I; Hartikainen, P; Seilhean, D; Galasko, D; Masliah, E; Cotman, C W; Tuñón, M T; Martínez, M C C; Munoz, D G; Carroll, S L; Marson, D; Riederer, P F; Bogdanovic, N; Schellenberg, G D; Hakonarson, H; Trojanowski, J Q; Lee, V M Y (2010). Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nature Genetics, 42(3):234-239.

Gmitterová, K; Heinemann, U; Bodemer, M; Krasnianski, A; Meissner, B; Kretzschmar, H A; Zerr, I (2009). 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiology of Aging, 30(11):1842-1850.

Krasnianski, A; von Ahsen, N; Heinemann, U; Meissner, B; Schulz-Schaeffer, W J; Kretzschmar, H A; Armstrong, V W; Zerr, I (2009). Increased frequency of positive family history of dementia in sporadic CJD. Neurobiology of Aging, 30(4):615-21.

Neumann, M; Rademakers, R; Roeber, S; Baker, M; Kretzschmar, H A; Mackenzie, I R A (2009). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain: A Journal of Neurology, 132(Pt 11):2922-2931.

Neumann, M; Roeber, S; Kretzschmar, H A; Rademakers, R; Baker, M; Mackenzie, I R A (2009). Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathologica, 118(5):605-616.

Wüllner, U; Schmitt, I; Kammal, M; Kretzschmar, H A; Neumann, M (2009). Definite multiple system atrophy in a German family. Journal of Neurology, Neurosurgery, and Psychiatry, 80(4):449-450.

Meissner, B; Kallenberg, K; Sanchez-Juan, P; Ramljak, S; Krasnianski, A; Heinemann, U; Eigenbrod, S; Gelpi, E; Barsic, B; Kretzschmar, H A; Schulz-Schaeffer, W J; Knauth, M; Zerr, I (2009). MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease. Journal of Neurology, 256(3):355-363.

Neumann, M; Kwong, L K; Lee, E B; Kremmer, E; Flatley, A; Xu, Y; Forman, M S; Troost, D; Kretzschmar, H A; Trojanowski, J Q; Lee, V M Y (2009). Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathologica, 117(2):137-149.

Krasnianski, A; Kallenberg, K; Collie, D A; Meissner, B; Schulz-Schaeffer, W J; Heinemann, U; Varges, D; Summers, D M; Kretzschmar, H A; Talbot, T; Will, R G; Zerr, I (2008). MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study. European Journal of Neurology, 15(8):762-771.

Heinemann, U; Krasnianski, A; Meissner, B; Grasbon-Frodl, E M; Kretzschmar, H A; Zerr, I (2008). Novel PRNP mutation in a patient with a slow progressive dementia syndrome. Medical Science Monitor, 14(5):CS41-43.

Krasnianski, A; von Ahsen, N; Heinemann, U; Meissner, B; Kretzschmar, H A; Armstrong, V W; Zerr, I (2008). ApoE distribution and family history in genetic prion diseases in Germany. Journal of Molecular Neuroscience, 34(1):45-50.

Heinemann, U; Krasnianski, A; Meissner, B; Kallenberg, K; Kretzschmar, H A; Schulz-Schaeffer, W; Zerr, I (2008). Brain biopsy in patients with suspected Creutzfeldt-Jakob disease. Journal of Neurosurgery, 109(4):735-741.

Krasnianski, A; Bartl, M; Sanchez Juan, P J; Heinemann, U; Meissner, B; Varges, D; Schulze-Sturm, U; Kretzschmar, H A; Schulz-Schaeffer, W J; Zerr, I (2008). Fatal familial insomnia: Clinical features and early identification. Annals of Neurology, 63(5):658-661.

Mittelbronn, M; Capper, D; Bader, B; Schittenhelm, J; Haybaeck, J; Weber, P; Meyermann, R; Kretzschmar, H A; Wietholter, H (2008). Severe hypoxia and multiple infarctions resembling Creutzfeldt-Jakob disease. Folia Neuropathologica, 46(2):149-153.

Ladogana, A; Puopolo, M; Croes, E A; Budka, H; Jarius, C; Collins, S; Klug, G M; Sutcliffe, T; Giulivi, A; Alperovitch, A; Delasnerie-Laupretre, N; Brandel, J-P; Poser, S; Kretzschmar, H A; Rietveld, I; Mitrova, E; Cuesta, J de Pedro; Martinez-Martin, P; Glatzel, M; Aguzzi, A; Knight, R; Ward, H; Pocchiari, M; van Duijn, C M; Will, R G; Zerr, I (2005). Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology, 64(9):1586-1591.

Pocchiari, M; Puopolo, M; Croes, E A; Budka, H; Gelpi, E; Collins, S; Lewis, V; Sutcliffe, T; Guilivi, A; Delasnerie-Laupretre, N; Brandel, J-P; Alperovitch, A; Zerr, I; Poser, S; Kretzschmar, H A; Ladogana, A; Rietvald, I; Mitrova, E; Martinez-Martin, P; de Pedro-Cuesta, J; Glatzel, M; Aguzzi, A; Cooper, S; Mackenzie, J; van Duijn, C M; Will, R G (2004). Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain: A Journal of Neurology, 127(10):2348-2359.

Grasbon-Frodl, E; Lorenz, H; Mann, U; Nitsch, R M; Windl, O; Kretzschmar, H A (2004). Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathologica, 108(6):476-484.

Budka, H; Aguzzi, A; Brown, P; Brucher, J M; Bugiani, O; Collinge, J; Diringer, H; Gullotta, F; Haltia, M; Hauw, J J; Ironside, J W; Kretzschmar, H A; Lantos, P L; Masullo, C; Pocchiari, M; Schlote, W; Tateishi, J; Will, R G (1996). [Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action]. Der Pathologe, 17(2):171-175.

This list was generated on Tue Oct 24 13:59:39 2017 CEST.